[A case of recurrent esophageal cancer with lung metastases successfully treated with docetaxel-combination chemotherapy]. 2006

Yuka Kobayashi, and Soichi Sugitani, and Shinichi Morita, and Masaya Nonaka, and Yuko Saito, and Shinichi Fujiwara, and Takashiro Hori, and Takao Iiri
Dept. of Gasteroenterology, Tachikawa General Hospital.

We report a case of a 67-year-old woman diagnosed with advanced esophageal cancer. She was treated with chemo-radiotherapy (5-FU/CDDP therapy and irradiation) initially, and primary lesion was well controlled. Two and a half years after first treatment, a chest CT showed multiple lung metastasis, which were confirmed by thoraco-laparoscopy. We chose docetaxel/CDDP combination chemotherapy, because of severe side effects due to the first treatment. After 3 courses, lung metastatic lesions were reduced. The following courses combining docetaxel-nedaplatin were done as ambulatory treatment. These regimens could be one choice for recurrent esophageal cancer, especially FP therapy-resistant or intolerant cases.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077143 Docetaxel A semisynthetic analog of PACLITAXEL used in the treatment of locally advanced or metastatic BREAST NEOPLASMS and NON-SMALL CELL LUNG CANCER. Docetaxel Anhydrous,Docetaxel Hydrate,Docetaxel Trihydrate,Docetaxol,N-Debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol,NSC 628503,RP 56976,RP-56976,Taxoltere Metro,Taxotere,N Debenzoyl N tert butoxycarbonyl 10 deacetyltaxol,RP56976
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Yuka Kobayashi, and Soichi Sugitani, and Shinichi Morita, and Masaya Nonaka, and Yuko Saito, and Shinichi Fujiwara, and Takashiro Hori, and Takao Iiri
March 2008, Gan to kagaku ryoho. Cancer & chemotherapy,
Yuka Kobayashi, and Soichi Sugitani, and Shinichi Morita, and Masaya Nonaka, and Yuko Saito, and Shinichi Fujiwara, and Takashiro Hori, and Takao Iiri
January 2012, Gan to kagaku ryoho. Cancer & chemotherapy,
Yuka Kobayashi, and Soichi Sugitani, and Shinichi Morita, and Masaya Nonaka, and Yuko Saito, and Shinichi Fujiwara, and Takashiro Hori, and Takao Iiri
October 2009, Gan to kagaku ryoho. Cancer & chemotherapy,
Yuka Kobayashi, and Soichi Sugitani, and Shinichi Morita, and Masaya Nonaka, and Yuko Saito, and Shinichi Fujiwara, and Takashiro Hori, and Takao Iiri
November 2014, Gan to kagaku ryoho. Cancer & chemotherapy,
Yuka Kobayashi, and Soichi Sugitani, and Shinichi Morita, and Masaya Nonaka, and Yuko Saito, and Shinichi Fujiwara, and Takashiro Hori, and Takao Iiri
March 2001, Gan to kagaku ryoho. Cancer & chemotherapy,
Yuka Kobayashi, and Soichi Sugitani, and Shinichi Morita, and Masaya Nonaka, and Yuko Saito, and Shinichi Fujiwara, and Takashiro Hori, and Takao Iiri
September 1999, Gan to kagaku ryoho. Cancer & chemotherapy,
Yuka Kobayashi, and Soichi Sugitani, and Shinichi Morita, and Masaya Nonaka, and Yuko Saito, and Shinichi Fujiwara, and Takashiro Hori, and Takao Iiri
December 2018, Gan to kagaku ryoho. Cancer & chemotherapy,
Yuka Kobayashi, and Soichi Sugitani, and Shinichi Morita, and Masaya Nonaka, and Yuko Saito, and Shinichi Fujiwara, and Takashiro Hori, and Takao Iiri
March 2002, Gan to kagaku ryoho. Cancer & chemotherapy,
Yuka Kobayashi, and Soichi Sugitani, and Shinichi Morita, and Masaya Nonaka, and Yuko Saito, and Shinichi Fujiwara, and Takashiro Hori, and Takao Iiri
June 2005, Gan to kagaku ryoho. Cancer & chemotherapy,
Yuka Kobayashi, and Soichi Sugitani, and Shinichi Morita, and Masaya Nonaka, and Yuko Saito, and Shinichi Fujiwara, and Takashiro Hori, and Takao Iiri
November 2015, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!